🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10259+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10259 recruiting trials

EARLY_Phase 1RecruitingNCT06942039

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

👨‍⚕️ Sylvia Cheng, BC Cancer Centre📍 12 sites📅 Started Sep 2025View details ↗
RecruitingNCT07315633

An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer

🏥 University Hospital, Ghent📍 1 site📅 Started Sep 2025View details ↗
RecruitingNCT07333612

IM Bands in Inactive Hepatic CE

🏥 Fondazione IRCCS Policlinico San Matteo di Pavia📍 1 site📅 Started Sep 2025View details ↗
Phase 1RecruitingNCT06865664

FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma

👨‍⚕️ Srivandana Akshintala, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Sep 2025View details ↗
Phase 1, PHASE2RecruitingNCT07111520

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

👨‍⚕️ BioNTech Responsible Person, BioNTech SE📍 2 sites📅 Started Sep 2025View details ↗
RecruitingNCT07214246

Follicular Fluid microRNAs in Ovarian Aging and Reproduction

👨‍⚕️ Michal Masternak, PhD, University of Central Florida📍 1 site📅 Started Sep 2025View details ↗
RecruitingNCT07314983

Long-term Anticoagulation in a Patient With Severe Hemophilia A

🏥 University Hospital, Strasbourg, France📍 1 site📅 Started Sep 2025View details ↗
NARecruitingNCT07191431

A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma(SELINA)

🏥 Ruijin Hospital📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07154264

A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)

👨‍⚕️ Niu, West China Hospital📍 15 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT06931652

Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab

👨‍⚕️ Hervé Pr. Ghesquieres, MD, HCL - Hôpital Lyon Sud - Service d'Hématologie - 165 Chemin du Grand Revoyet, 69310 Pierre-Bénite - France📍 13 sites📅 Started Sep 2025View details ↗
NARecruitingNCT07140731

The Symani Restore Study

🏥 Jacobs institute📍 1 site📅 Started Sep 2025View details ↗
EARLY_Phase 1RecruitingNCT07162012

Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma

🏥 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Sep 2025View details ↗
Phase 1, PHASE2RecruitingNCT07203599

A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes

🏥 Shenzhen People's Hospital📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07157787

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

🏥 Alexion Pharmaceuticals, Inc.📍 39 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT06946797

A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)

👨‍⚕️ Bristol-Myers Squibb, Bristol-Myers Squibb📍 50 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07170800

A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

🏥 WestVac Biopharma Co., Ltd.📍 7 sites📅 Started Sep 2025View details ↗
Phase 4RecruitingNCT07072988

Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod

🏥 Centre Hospitalier Universitaire de Nice📍 1 site📅 Started Sep 2025View details ↗
Phase 3RecruitingNCT06497465

Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

👨‍⚕️ Ethel M Weld, MD, Johns Hopkins University📍 6 sites📅 Started Sep 2025View details ↗
RecruitingNCT07144839

Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation

👨‍⚕️ Karen Gibbins, Oregon Health and Science University📍 1 site📅 Started Sep 2025View details ↗
RecruitingNCT06837181

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

🏥 Jaeb Center for Health Research📍 18 sites📅 Started Sep 2025View details ↗
← PreviousPage 63 of 513Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →